Device type · DCN
System, Test, C-Reactive Protein
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DCN
Immunology
Device class
Class II
FDA decisions since 2015
7
510(k), De Novo and PMA
Adverse event reports
7
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- System, Test, C-Reactive Protein
- Product code
- DCN
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5270
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DCN
Latest FDA decisions
- CardioPhase® hsCRP510(k)
Siemens Healthcare Diagnostic Products GmbH
K232624 · Decided Nov 27, 2023 · 90 days after receipt
Device type: System, Test, C-Reactive Protein (DCN) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics, Inc.
K221119 · Decided Mar 17, 2023 · 333 days after receipt
Device type: System, Test, C-Reactive Protein (DCN) · Laboratory Medicine & Pathology
Roche Diagnostics Operations (Rdo)
K192072 · Decided Feb 21, 2020 · 203 days after receipt
Device type: System, Test, C-Reactive Protein (DCN) · Laboratory Medicine & Pathology
4 more FDA decisions with a free account
Reports received
7
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
6
86% of reports
Injury reports
1
14% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 1 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 1 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results3
- Non Reproducible Results3
- Chemical Problem1
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions6
- Insufficient Information1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-3335-2026 · Started Aug 17, 2026 · Posted by FDA Oct 1, 2026
Reason given: The potential for falsely elevated results.
Cause as FDA categorized it: Under Investigation by firm
- Atellica CH Revised C Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223.Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-1551-2025 · Started Mar 11, 2025 · Posted by FDA Apr 10, 2025
Reason given: Incorrect software flagging may occur for the assay that may potentially lead to an erroneous result.
Cause as FDA categorized it: Software Design Change
Roche Diagnostics Operations, Inc.
Z-0634-2021 · Started Nov 6, 2020
Reason given: Roche confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the Tina-quant C-Reactive Protein Gen. 3 on the cobas c701 and 702 modules. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
Cause as FDA categorized it: Process control
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.